Description
Luspatercept in lower-risk myelodysplastic syndromes: Belgian real-life data into perspective
Article: Luspatercept in lower-risk myelodysplastic syndromes: Belgian real-life data into perspective
€3.03
€3.03
Luspatercept in lower-risk myelodysplastic syndromes: Belgian real-life data into perspective
Top
Notifications
Reviews
There are no reviews yet.